Weight Loss Study: AI Pre-Screening
Oncology Case Study: 66% faster enrollment time
Phase III Atopic Dermatitis: 123% of Inato's patient enrollment achieved
Asthma Case Study: 181% of Inato’s patient enrollment achieved
Phase III CVD: 115% of Inato's patient enrollment achieved
Phase III COPD Case Study: 85% of patients were diverse
